Arginase I mRNA therapy – a novel approach to rescue arginase 1 enzyme deficiency
- 3 July 2018
- journal article
- research article
- Published by Taylor & Francis in RNA Biology
- Vol. 15 (7) , 914-922
Abstract
Arginase I (ARG1) deficiency is an autosomal recessive urea cycle disorder, caused by deficiency of the enzyme Arginase I, resulting in accumulation of arginine in blood. Current Standard of Care (SOC) for ARG1 deficiency in patients or those having detrimental mutations of ARG1 gene is diet control. Despite diet and drug therapy with nitrogen scavengers, ~25% of patients suffer from severe mental deficits and loss of ambulation. 75% of patients whose symptoms can be managed through diet therapy continue to suffer neuro-cognitive deficits. In our research, we demonstrate in vitro and in vivo that administration of ARG1 mRNA increased ARG1 protein expression and specific activity in relevant cell types, including ARG1-deficient patient cell lines, as well as in wild type mice for up to 4 days. These studies demonstrate that ARG1 mRNA treatment led to increased functional protein expression of ARG1 and subsequently an increase in urea. Hence, ARG1 mRNA therapy could be a potential treatment option to develop for patients.Keywords
Funding Information
- Alexion Pharmaceuticals
This publication has 30 references indexed in Scilit:
- A long-term survival case of arginase deficiency with severe multicystic white matter and compound mutationsBrain and Development, 2011
- Short-term Correction of Arginase Deficiency in a Neonatal Murine Model With a Helper-dependent Adenoviral VectorMolecular Therapy, 2009
- Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2The International Journal of Biochemistry & Cell Biology, 2007
- Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto UniversityLiver Transplantation, 2005
- Hyperargininemia due to liver arginase deficiencyMolecular Genetics and Metabolism, 2005
- A successful trial of enzyme replacement therapy in a case of argininemia.The Tohoku Journal of Experimental Medicine, 1984
- Hollow-fiber reactors containing mammalian arginase: An approach to enzyme replacement therapyBiochemical Medicine, 1982
- Arginase deficiency in multiple tissues in argininemiaClinical Genetics, 1978
- ArgininemiaThe Journal of Pediatrics, 1977
- Unsuccessful trial of gene replacement in arginase deficiencyEuropean Journal of Pediatrics, 1975